Companies & Industry »Company News»Company News Details
Company News Details

BSE   30 Sep 14 | 12:00 AM

1323.80 -5.4 (-0.41%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   30 Sep 14 | 12:00 AM

1322.05 -7.75 (-0.58%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 1,278.15 (3.57%)
1 Month : Rs 1,200.40 (10.28%)
1 Year : Rs 680.00 (94.68%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Sensex

Company Price Gain (%)
Sun Pharma.Inds.857.302.77
H D F C1,052.602.17
Bajaj Auto2,348.951.96
Maruti Suzuki3,064.351.85
Cipla625.701.59

Online Portfolio

You can create Online Portfolio here using the below button.